This is the authors' abstract. We don't add key points for this paper.
This study evaluated ovarian and estrous responses as affected by day of the estrous cycle at initiation of treatment among cows synchronized with the Select Synch protocol. Fifty-six suckled Hereford x Red Angus multiparous cows were fitted with HeatWatch® electronic estrous detection monitors 22 d before initiation of treatment. Thirty-two percent of cows were not detected in estrus during this 22-d period, and were classified as anestrus. Treatment included an injection of Gonadotropin releasing hormone (GnRH; 100 μg) on d 7, followed by an injection of Prostaglandin F2α (PGF2α; 25 mg) on d 0. Ovaries of cows were scanned daily via ultrasound from d 12 until the time of insemination to evaluate follicular and luteal response to the GnRH and PGF2α injections. Cows were visually observed for signs of estrus twice daily from d 0 to d 5 for approximately 2 h to compare visual detection of estrus with electronic detection. There was no difference (P>0.5) in the percentage of cows detected in estrus between visual (85%) and electronic (88%) observation. Ovarian and estrous responses to the GnRH and PGF2α injections were dependent on day of the estrous cycle when the protocol was initiated. Ovulation resulting in formation of a new corpus luteum (CL) and follicular turnover occurred following the injection of GnRH in 66 and 70% of cows, respectively. Only 14% of cows that were between d 15 and 17 of their estrous cycle responded to either GnRH or PGF2α administration. Additionally, these cows exhibited estrus 11 ± 19 h (mean ± SD) before injection of PGF2α. Anestrous cows exhibited estrus earlier (P<0.05) than cyclic cows (40.2 ± 16 h and 56.3 ± 39 h, respectively). Synchronized pregnancy rate was 71% for the 5 d breeding period, and included a 61% pregnancy rate among anestrous cows. We conclude that the Select Synch protocol is capable of synchronizing estrus among the majority of cows in a herd, and we emphasize that accurate estrous detection beginning 24 to 30 h before the PGF2α injection is important.
No takes yet. Share an insight, caveat, or question.
Geary et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: